订阅小程序
旧版功能

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.

Theodoros P. Vassilakopoulos,Michail,Sotirios Papageorgiou,Georgia Kourti,Maria K. Angelopoulou,Fotios Panitsas,Sotirios Sachanas,Christina Kalpadakis,Eirini Katodritou,Theoni Leonidopoulou,Ioannis Kotsianidis,Eleftheria Hatzimichael,Maria Kotsopoulou,Maria Dimou,Eleni Variamis,Dimitrios Boutsis,Evangelos Terpos,Maria N. Dimopoulou,Stamatios Karakatsanis,Eurydiki Michalis,George Karianakis,Pantelis Tsirkinidis,Chryssa Vadikolia,Christos Poziopoulos,Anna Pigaditou,Effimia Vrakidou,Theophanis Economopoulos,Lydia Kyriazopoulou,Marina P. Siakantaris,Marie-Christine Kyrtsonis,Argyris Symeonidis,Konstantinos Anargyrou,Maria Papaioannou,Evdoxia Hatjiharissi,Elissavet Vervessou,Maria Tsirogianni,Maria Palassopoulou,Gabriella Gainaru,Ekaterini Stefanoudaki,Panayiotis Zikos,Panayiotis Tsirigotis,Gerasimos Tsourouflis,Theodora Assimakopoulou,Pavlina Konstantinidou,Helen A. Papadaki,Katerina Megalakaki,Meletios-Athanasios Dimopoulos,Vassiliki Pappa,Themis Karmiris,Paraskevi Roussou,Panayiotis Panayiotidis,Kostas Konstantopoulos,Gerassimos A. Pangalis

The Oncologist（2021）

引用 23|浏览20
关键词
Prognostic factors,Rituximab,CHOP,Large B-cell lymphoma,Primary mediastinal
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要